Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results [Phase 1]
This Phase 1 trial update reports safety data and early results for GH21 capsules in patients with advanced solid tumors, including non-smal…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC [Phase 3]
Phase 3 clinical trial comparing MB12 to pembrolizumab (Keytruda) in stage IV non-small cell lung cancer is currently recruiting to evaluate…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
A clinical trial update investigating whether prodigiosin or pioglitazone can modulate the tumor immune microenvironment and its crosstalk w…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Study of Crizotinib for ROS1 and MET Activated Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating crizotinib for ROS1-rearranged and MET-activated non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
This is a prospective study to validate blood-based biomarkers associated with differences in the efficacy of neoadjuvant therapy for non-sm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors
This clinical trial update reports on progression-free survival and participant experience for metastatic ALK-positive non-small cell lung c…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer. [NA]
This clinical trial update describes the assessment of invasive mediastinal staging in patients with cN1 non-small cell lung cancer. The stu…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence
This completed study reviews the use and findings of low-dose CT lung cancer screening within a high-incidence community healthcare system.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy
Completed real-world study of locally advanced or metastatic non-small cell lung cancer patients who progressed after first-line EGFR-TKI th…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
Clinical trial update noting the completion of a study evaluating dynamic perfusion computed tomography in patients with localized non-small…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients
This clinical trial registration describes a study of immunotherapy in first-line PD-L1-negative advanced non-small cell lung cancer and ind…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating RO5126766 in patients with advanced KRAS-mutant non-small ce…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations [Phase 1]
Phase 1 clinical trial evaluating BPI-1178 in combination with Osimertinib for advanced non-small cell lung cancer with EGFR mutations; curr…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
Clinical trial investigating the identification and characterization of sleep disorders in a population of patients with non-small cell lung…
-
CLINICAL_TRIALS withdrawal · 2024-07-09Clinical Trial Update: Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating a targeted RET therapy for RET-positive advanced non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant intra-tumor double immunotherapy for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC [Phase 3]
Phase III study comparing toripalimab plus chemotherapy to placebo plus chemotherapy in resectable stage II-III non-small cell lung cancer. …
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC [Phase 2]
This entry notes a Phase 2 neoadjuvant immunotherapy trial for localized non-small cell lung cancer with an EGFR activating mutation, curren…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC [Phase 1, Phase 2]
An ongoing Phase Ib/II trial is evaluating GH21 capsules in combination with osimertinib for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery [Phase 1]
A Phase 1 study evaluating the combination of docetaxel, cisplatin, and erlotinib in patients with Stage I-III non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of dasatinib and osimertinib in advanced EGFR-mutant non-small cell lung cancer has been termin…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants [Phase 1]
Phase 1 study to evaluate how food and the proton pump inhibitor esomeprazole affect BAY2927088 blood levels in healthy participants.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of AMG 160 in non-small cell lung cancer was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants [Phase 1]
Phase 1 study to learn how BAY2927088 affects blood levels of dabigatran and rosuvastatin when taken together in healthy participants; spons…